SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (6795)4/10/1998 12:51:00 PM
From: Mkilloran  Read Replies (1) of 23519
 
Vlad and All....
The old plant produced and sold 1.8 mill units in 1st qtr....the production line that was moved in the 4th qtr 97 to the new plant was replaced later. The main reason that they pulled one of the three lines from the old plant to the new was to avoid any issues related to new equiptment and staff to get MCA and FDA approval in the new plant. Also to clarify earlier post........VVUS does NOT see a need to raise additional capital. They can use existing cash and cash flow...this question was raised in yesterdays con call ...by the analyst from Prudential Secuities...Another key point that surfaced in yesterdays conf call is that the UK sales numbers provided thru Astra by Walsh Co/now part of IMS show VVUS has captured 27% of the ED market in the UK in the lst 4 1/2 weeks.
Now factor in the led times...UK approval in Dec 97 ...but they are just 4 1/2 weeks into sales stats. Argentina, Brazil, South Korea, Switzerland just approved....I'd expect to see the benifits of these countries in 3rd qtr 98. Unitd urope expected late 4qtr ealy 1st qtr 99...plant in Ireland moving ahead as planned...additional mgt staff announced to key positions.

Questions as to when China, Mexico, Canada, etc wil be approved can not be answered by VVUS mgt...they are dependent on the approiate govt
approvals in each country.

VVUS mgt has cofidence in the value of this company as demonstrated in the stock buyback in 97 and early 98...2mill sares total 1.63 during the first qtr 98......we all wish we ha 20/20 hindsite and bought at the lwest price ourselves...

I for one was pleased to here their plan to concentrate on spending adv budget dollars on educating Dr's on benifits of Muse over Viagra and details of where Muse was more approiate...ramp up of the contract sales force was expected early on and several key personnel are inplace already....education of contract sales force starts next week.. Let Pfe spend the big $$$ on binging the paients into the Dr's offices.

3rd/4th qtr 98 looks very good .....look to 1999 eps concensus $2.91 on Zacks........This board seems to be pre-occupied by daytraders comments....Long term view and mgt's stock buyback will payoff in 1999 and beyond.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext